弥漫性大B细胞淋巴瘤-话题@MedSci

#弥漫性大B细胞淋巴瘤#

54篇内容 | 4961人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1290152, encodeId=a9951290152a3, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, objectType=article, longId=155103, objectId=ddf415510378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf415510378, replyNumber=0, likeNumber=90, createdTime=2018-12-06, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf415510378, moduleTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf415510378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290151, encodeId=71ba129015131, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, objectType=article, longId=154662, objectId=d1d31546622a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d31546622a, replyNumber=0, likeNumber=76, createdTime=2018-12-01, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d31546622a, moduleTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d31546622a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290150, encodeId=6260129015047, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, objectType=article, longId=154562, objectId=e874154562ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e874154562ec, replyNumber=0, likeNumber=0, createdTime=2018-11-30, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e874154562ec, moduleTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e874154562ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290149, encodeId=c3211290149e4, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, objectType=article, longId=148786, objectId=bee6148e86b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee6148e86b0, replyNumber=0, likeNumber=91, createdTime=2018-09-15, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee6148e86b0, moduleTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee6148e86b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290148, encodeId=1820129014888, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, objectType=article, longId=145217, objectId=49aa14521efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49aa14521efb, replyNumber=0, likeNumber=0, createdTime=2018-07-27, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49aa14521efb, moduleTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49aa14521efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290147, encodeId=bff7129014e8e, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, objectType=article, longId=144538, objectId=cc1d14453882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d14453882, replyNumber=0, likeNumber=103, createdTime=2018-07-18, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d14453882, moduleTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d14453882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290146, encodeId=000c12901463d, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, objectType=article, longId=135549, objectId=cdbc1355495e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdbc1355495e, replyNumber=0, likeNumber=89, createdTime=2018-04-18, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdbc1355495e, moduleTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdbc1355495e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290145, encodeId=da07129014577, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, objectType=article, longId=133365, objectId=e4531333650d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4531333650d, replyNumber=0, likeNumber=100, createdTime=2018-03-26, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4531333650d, moduleTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4531333650d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290144, encodeId=eaa9129014415, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, objectType=article, longId=129689, objectId=eb3012968908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3012968908, replyNumber=0, likeNumber=54, createdTime=2018-02-13, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3012968908, moduleTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb3012968908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290143, encodeId=650b129014309, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, objectType=article, longId=128600, objectId=c14a1286000a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14a1286000a, replyNumber=0, likeNumber=77, createdTime=2018-02-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14a1286000a, moduleTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14a1286000a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290142, encodeId=a3b21290142b6, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, objectType=article, longId=107726, objectId=94d510e7261d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94d510e7261d, replyNumber=0, likeNumber=70, createdTime=2017-08-06, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94d510e7261d, moduleTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94d510e7261d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290141, encodeId=0b76129014178, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, objectType=article, longId=104214, objectId=35571042148f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35571042148f, replyNumber=0, likeNumber=74, createdTime=2017-07-02, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35571042148f, moduleTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35571042148f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290140, encodeId=76591290140e1, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, objectType=article, longId=103953, objectId=9e52103953a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e52103953a4, replyNumber=0, likeNumber=83, createdTime=2017-07-01, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e52103953a4, moduleTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e52103953a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290139, encodeId=f045129013978, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。, objectType=article, longId=103296, objectId=e8f51032963e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8f51032963e, replyNumber=0, likeNumber=75, createdTime=2017-06-26, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8f51032963e, moduleTitle=Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8f51032963e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290138, encodeId=d9881290138e6, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？, objectType=article, longId=97762, objectId=904e9e7626b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=904e9e7626b, replyNumber=0, likeNumber=68, createdTime=2017-05-04, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=904e9e7626b, moduleTitle=Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=904e9e7626b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290137, encodeId=880f129013e62, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后, objectType=article, longId=81966, objectId=15ec819669e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15ec819669e, replyNumber=0, likeNumber=66, createdTime=2016-11-09, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15ec819669e, moduleTitle=JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15ec819669e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290136, encodeId=77441290136e7, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=2016NCCN临床实践指南——非霍奇金淋巴瘤：弥漫性大B细胞淋巴瘤-证据块（2016.V2）发布, objectType=article, longId=79742, objectId=3eeee9742c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eeee9742c2, replyNumber=0, likeNumber=80, createdTime=2016-10-12, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eeee9742c2, moduleTitle=2016NCCN临床实践指南——非霍奇金淋巴瘤：弥漫性大B细胞淋巴瘤-证据块（2016.V2）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eeee9742c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290135, encodeId=bcb9129013566, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=JNCI：弥漫性大B细胞淋巴瘤幸存者的身体成分变化研究, objectType=article, longId=78136, objectId=7ef2e8136f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ef2e8136f9, replyNumber=0, likeNumber=87, createdTime=2016-09-23, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ef2e8136f9, moduleTitle=JNCI：弥漫性大B细胞淋巴瘤幸存者的身体成分变化研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ef2e8136f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290134, encodeId=0df01290134bb, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小, objectType=article, longId=48969, objectId=a8984896926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8984896926, replyNumber=0, likeNumber=80, createdTime=2015-04-05, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8984896926, moduleTitle=JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8984896926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290133, encodeId=d9c512901337f, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后, objectType=article, longId=7374, objectId=d039e37452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d039e37452, replyNumber=0, likeNumber=76, createdTime=2012-06-27, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d039e37452, moduleTitle=JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d039e37452)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

弥漫性大B细胞淋巴瘤

2020-05-29

bnjfy

#弥漫性大B细胞淋巴瘤#

NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤

2018-12-06

bnjfy

#弥漫性大B细胞淋巴瘤#

腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例

2018-12-01

bnjfy

#弥漫性大B细胞淋巴瘤#

2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理

2018-11-30

bnjfy

#弥漫性大B细胞淋巴瘤#

Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号

2018-09-15

bnjfy

#弥漫性大B细胞淋巴瘤#

Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变

2018-07-27

bnjfy

#弥漫性大B细胞淋巴瘤#

Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？

2018-07-18

bnjfy

#弥漫性大B细胞淋巴瘤#

NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步

2018-04-18

bnjfy

#弥漫性大B细胞淋巴瘤#

Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药

2018-03-26

bnjfy

#弥漫性大B细胞淋巴瘤#

2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用

2018-02-13

zhouqu_8

#弥漫性大B细胞淋巴瘤#

Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果

2018-02-04

bnjfy

#弥漫性大B细胞淋巴瘤#

Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。

2017-08-06

bnjfy

#弥漫性大B细胞淋巴瘤#

SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！

2017-07-02

bnjfy

#弥漫性大B细胞淋巴瘤#

Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究

2017-07-01

bnjfy

#弥漫性大B细胞淋巴瘤#

Blood：弥漫性大B细胞淋巴瘤的tonic BCR信号通路。

2017-06-26

bnjfy

#弥漫性大B细胞淋巴瘤#

Leuk Lymphoma：体重指数可以预测弥漫性大B细胞淋巴瘤的结局吗？

2017-05-04

bnjfy

#弥漫性大B细胞淋巴瘤#

JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后

2016-11-09

bnjfy

#弥漫性大B细胞淋巴瘤#

2016NCCN临床实践指南——非霍奇金淋巴瘤：弥漫性大B细胞淋巴瘤-证据块（2016.V2）发布

2016-10-12

zhaojie88

#弥漫性大B细胞淋巴瘤#

JNCI：弥漫性大B细胞淋巴瘤幸存者的身体成分变化研究

2016-09-23

bnjfy

#弥漫性大B细胞淋巴瘤#

JCO：无症状弥漫性大B细胞淋巴瘤（ DLBCL ）影像监控获益小

2015-04-05

bnjfy

#弥漫性大B细胞淋巴瘤#

JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后

2012-06-27